中文名称: 缬沙坦
英文名称: Valsartan
CAS No: 137862-53-4
分子式: C24H29N5O3
分子量: 435.52
V10132 缬沙坦 ≥98% (psaitong)
包装规格:
100g in glass bottle
溶解性:
溶于DMSO(≥100mg/mL)
产品描述:

基本信息

产品编号:V10132

产品名称:Valsartan

CAS:

137862-53-4

 

储存条件

粉末

室温

四年

 

 

分子式:

C24H29N5O3

溶于液体

-80℃

六个月

分子量:

435.52

-20℃

一个月

化学名: 

 

 

Solubility (25°C)

 

体外

DMSO

87mg/mL (199.76mM)

Ethanol

87mg/mL (199.76mM)

Water

Insoluble

体内(现配现用)

 

 

1mg/ml表示微溶或不溶。

普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。

 

制备储备液

 

浓度

 

溶液体积

质量

 

1mg

 

5mg

 

10mg

1mM

2.2961mL

11.4805mL

22.9611mL

5mM

0.4592mL

2.2961mL

4.5922mL

10mM

0.2296mL

1.1481mL

2.2961mL

50mM

0.0459mL

0.2296mL

0.4592mL

 

生物活性

产品描述

一种血管紧张素 II (angiotensin II) 受体拮抗剂,有潜力用于高血压和心力衰竭的研究。

靶点/IC50

angiotensin II receptor

 

体外研究

Valsartan (CGP 48933) is a synthetic non-peptide angiotensin II type 1 receptor antagonist that dilates blood vessels and reduces blood pressure by blocking the action of angiotensin.Valsartan significantly decreases the expression of AT1R in ageing aorta endothelial cells.The pretreatment of valsartan results in an inhibition of TLR2 signaling and proinflammatory cytokines.The expression of AGTR1 is up-regulated after alcohol exposure,and is blocked by valsartan pretreatment.

体内研究

Valsartan (CGP 48933) significantly attenuates the expression of TGF-β/Smad, Hif-1αand fibrosis-related protein in rats after MI.Heart function,infarcted size,wall thickness as well as myocardial vascularization of ischaemic hearts are also significantly improved by valsartan compared with saline and hydralazine.Valsartan partially reverses the effects of high-salt diet on hypertension,cardiac injuries such as fibrosis and inflammatory cell infiltration,and inhibition of aquaporin 1 and angiogenic factors;valsartan alone does not exert such effects.Valsartan is an effective antidepressant/antianxiety reagent and can promote the hippocampal neurogenesis and expression of BDNF.Chronic administration of valsartan (5-40mg/kg/d,p.o.) increases the time spent in the center of the field in OFT and the latency to eat in NSF,reduces the immobility time in both TST and FST,and increases the sucrose preference in SPT.

 

推荐实验方法(仅供参考)

动物实验:

 

Rats:
Rats are randomly divided into two groups:(i) valsartan-treated group that is given intravenously 3mg/kg/day valsartan in 0.5mL normal saline via the vein daily for 1 week;(ii) hydralazine-treated group receiving 0.2mg/kg/day hydralazine injection in saline; and (iii) control group that receives saline injection in the same way (n=15 for each group).

保存条件:
室温
UN码:
HazardClass:
危害声明:
安全说明:
搜索质检报告(COA)
参考文献 & 客户发表文献

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • =
    *
    *
    *选择对应的单位 *空出希望得到的变量,填写另外两个变量

用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )

  • * = *

连续稀释计算器方程

  • 连续稀释

  • 初始浓度:
  • 稀释倍数:
  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):